The FSA Spy market buzz – 26 April 2024
Golden mystery, Next big Healthtech thing, Plastic everywhere, The Magnificent Seven wane, Dreary fund presentation hell, Putting The Economist in its place, A touch of Shakespeare and much more.
The Axa fund receives a one-star Morningstar rating and an analyst rating of Neutral, while the Invesco product receives three-stars and also a Neutral analyst rating.
Morningstar’s star rating looks at historical risk-adjusted performance and the analyst rating is based on forward-looking analysis.
Chelsea’s McDermott is positive on both funds as they have different roles to play in a portfolio.
“We like both funds for different reasons. The Axa fund is a more defensive fixed income element in a portfolio.” For investors concerned about rising interest rates or inflation, the Axa product could be a consideration, he said.
“If you are more positive on bonds and think interest rates have peaked, the Invesco fund may appeal more,” McDermott said.
Golden mystery, Next big Healthtech thing, Plastic everywhere, The Magnificent Seven wane, Dreary fund presentation hell, Putting The Economist in its place, A touch of Shakespeare and much more.
Part of the Mark Allen Group.